The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dosimetry of lutetium-177-PSMA-I&T radioligand therapy in recurrent/metastatic adenoid cystic carcinoma.
 
Niels J. van Ruitenbeek
No Relationships to Disclose
 
Steffie M.B. Peters
No Relationships to Disclose
 
Maike J.M. Uijen
No Relationships to Disclose
 
Chantal M.L. Driessen
No Relationships to Disclose
 
Martin Gotthardt
No Relationships to Disclose
 
Mark W. Konijnenberg
No Relationships to Disclose
 
Carla M.L.- van Herpen
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Elevar Therapeutics; Ipsen; MSD; Regeneron
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; MSD; Novartis; Sanofi
 
James Nagarajah
No Relationships to Disclose